Perfluorocarbon attenuates lipopolysaccharide-mediated inflammatory responses of alveolar epithelial cells in vitro

Chinese Medical Journal

Volumn 124, Issue 16, 2011, Pages 2534-2539

  Xu, Shu Feng ^a   Wang, Ping ^a   Liu, Rui Ji ^b   Zhao, Jing ^b   Zhang, Xiang Ning ^b   Fu, Zhan Zhao ^b   Gao, Li Ming ^b   Liang, Zhi Xin ^a   Sun, Ji Ping ^c   Chen, Liang An ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FIRST HOSPITAL OF QINHUANGDAO   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Alveolar epithelial cells; Lipopolysaccharide; Nuclear factor b; Perfluorocarbon; Toll like receptor 4

Indexed keywords

FLUOROCARBON; I KAPPA B KINASE ALPHA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; NUCLEOTIDE SEQUENCE; PROTEIN SECRETION; PROTEIN TRANSPORT; RADIOIMMUNOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; EPITHELIAL CELLS; FLUOROCARBONS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NF-KAPPA B; PULMONARY ALVEOLI; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051994179     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.16.025     Document Type: Article

References (29)

1. Li X, Tupper JC, Bannerman DD, Winn RK, Rhodes CJ, Harlan JM. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun 2003; 71: 4414-4420.
2. Lee JS, Frevert CW, Matute-Bello G, Wurfel MM, Wong VA, Lin SM, et al. TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am J Physiol Lung Cell Mol Physiol 2005; 289: L731-L738.
3. Chi XJ, Cai J, Luo CF, Cheng N, Hei ZQ, Li SR, et al. Relationship between the expression of Toll-like receptor 2 and 4 in mononuclear cells and postoperative acute lung injury in orthotopic liver transplantation. Chin Med J 2009; 122: 895-899.
4. Hu G, Malik AB, Minshall RD. Toll-like receptor 4 mediates neutrophil sequestration and lung injury induced by endotoxin and hyperinflation. Crit Care Med 2010; 38: 194-201.
5. Abraham E. Alterations in cell signaling in sepsis. Clin Infect Dis 2005; 4(Suppl 7): S459-S464.
6. Shang Y, Jiang YX, Xu SP, Wu Y, Wu ZY, Yuan SY, et al. Reduction of pulmonary inflammatory response by erythropoietin in a rat model of endotoxaemia. Chin Med J 2009; 122: 834-838.
7. Wissel H, Schulz C, Koehne P, Richter E, Maass M, Rüdiger M. Chlamydophila pneumoniae induces expression of Toll-like Receptor 4 and release of TNF-α and MIP-2 via an NF-κB pathway in rat type II pneumocytes. Respir Res 2005; 6: 51.
8. Tian F, Ni YF, Zhao JB, Zhang ZP, Zhang HZ, Liu L, et al. Single immunoglobulin IL-1 receptor-related protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells. Chem Biol Interact 2010; 183: 442-449.
9. Mendez MP, Morris SB, Wilcoxen S, Du M, Monroy YK, Remmer H, et al. Disparate mechanisms of sICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294: L807-L814.
10. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369: 1553-1564.
11. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008; 336: 1006-1009.
12. Shashikant BN, Miller TL, Jeng MJ, Davis J, Shaffer TH, Wolfson MR. Differential impact of perfluorochemical physical properties on the physiologic, histologic, and inflammatory profile in acute lung injury. Crit Care Med 2005; 33: 1096-1103.
13. von der Hardt K, Schoof E, Kandler MA, Dötsch J, Rascher W. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res 2002; 51: 177-182.
14. Qin X, Liu YN. Effect of vaporized perfluorocarbon inspiration on cell apoptosis of intestine mucosa: experiment with pigs with acute lung injury. Natl Med J China (Chin) 2007; 87: 493-496.
15. Chang H, Kuo FC, Lai YS, Chou TC. Inhibition of inflammatory responses by FC-77, a perfluorochemical, in lipopolysaccharide-treated RAW 264.7 macrophages. Intensive Care Med 2005; 31: 977-984.
16. Ge ZJ, Jiang GJ, Zhao YP, Wang GX, Tan YF. Systemic perfluorohexane attenuates lung injury induced by lipopolysaccharide in rats: the role of heme oxygenase-1. Pharmacol Rep 2010; 62: 170-177.
17. Liu SY, Fan HJ, Qian GS, Zhang JP. Perfluorocarbons injected intraperitoneally suppress neutrophilic infiltration in lipopolysaccharide-induced lung injury in rats. Chin J Tuber Res Dis (Chin) 2006; 29: 674-678.
18. Fan HJ, Liu SY, Zhang JP, Zhao XW, Gao HM, Liu YN. The preventive effects of intraperitoneal injection of perfluorocarbon on acute lung injury in rat. Chin Crit Care Med (Chin) 2008; 20: 100-103.
19. dos Santos CC, Han B, Andrade CF, Bai X, Uhlig S, Hubmayr R, et al. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. Physiol Genomics 2004; 19: 331-342.
20. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
21. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
22. MacRedmond R, Greene C, Taggart CC, McElvaney N, O'Neill S. Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respir Res 2005; 6: 116.
23. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, et al. Expression of functional Toll-like receptor (TLR-)2 and TLR-4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004; 31: 241-245.
24. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, et al. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like Receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 2004; 279: 2712-2718.
25. Babu PB, Chidekel A, Shaffer TH. Hyperoxia-induced changes in human airway epithelial cells: The protective effect of perflubron. Pediatr Crit Care Med 2005; 6: 188-194.
26. von der Hardt K, Kandler MA, Fink L, Schoof E, Dotsch J, Bohle RM, et al. Laser-assisted microdissection and real-time PCR detect anti-inflammatory effect of perfluorocarbon. Am J Physiol Lung Cell Mol Physiol 2003; 285: L55-L62.
27. Nakata S, Yasui K, Nakamura T, Kubota N, Baba A. Perfluorocarbon suppresses lipopolysaccharide- and alpha-toxin-induced interleukin-8 release from alveolar epithelial cells. Neonatology 2007; 91: 127-133.
28. Rotta AT, Gunnarsson B, Fuhrman BP, Wiryawan B, Hernan LJ, Steinhorn DM. Perfluorooctyl bromide (perflubron) attenuates oxidative injury to biological and nonbiological systems. Pediatr Crit Care Med 2003; 4: 233-238.
29. Wissel H, Burkhardt W, Rupp J, Wauer RR, Rüdiger M. Perfluorocarbons decrease Chlamydophila pneumoniae-mediated inflammatory responses of rat type II pneumocytes in vitro. Pediatr Res 2006; 60: 264-269.